
Currently out of the existing stock ratings of James Molloy, 60 are a BUY (96.77%), 2 are a HOLD (3.23%).
Analyst James Molloy, currently employed at ALLIANCE GLOBAL PARTNERS, has had 32.35% of price targets met with an average potential upside of 52.73%, reached in 257 days on average. Previously, James Molloy worked at LAIDLAW, JANNEY, SUMMER STREET.
James Molloy has documented 111 price targets and ratings displayed on 19 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on SLS, Sellas Life Sciences Group at 06-Jul-2026.
Analyst best performing recommendations are on PDSB.
The best stock recommendation documented was for PDSB on 5/27/2020. The price target of $4 was fulfilled within 54 days with a profit of $2.78 (227.87%), with a performance score of 42.2.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 03-Aug-2023
$19
$19
3 years 1 months 26 days ago
(27-Sep-2023)
8/12 (66.67%)
$19 (0.00%)
435
Hold Since 14-Aug-2023
$19
3 years 1 months 26 days ago
(27-Sep-2023)
1/7 (14.29%)
$19 (0.00%)
41
Hold Since 10-Nov-2020
$19
$13
3 years 1 months 26 days ago
(27-Sep-2023)
8/26 (30.77%)
$19 (0.00%)
246
Buy Since 03-Aug-2023
$19
$20
3 years 1 months 26 days ago
(27-Sep-2023)
2/8 (25%)
$19 (0.00%)
86
Buy Since 10-May-2022
$19
$15
3 years 1 months 26 days ago
(27-Sep-2023)
3/17 (17.65%)
$19 (0.00%)
340
Stocks James Molloy covered previously. Scores are shown for active stocks only.
The record of these past calls is part of the data set at anachart.store.
Which stock is James Molloy most bullish on?
What Year was the first public recommendation made by James Molloy?